title: Antinociceptive activity of CC44, a biotinylated improgan congener.
abstract: Improgan, a non-opioid, antinociceptive drug, activates descending analgesic circuits following brain administration, but the improgan receptor remains unidentified. Since biotinylation of drugs can enhance drug potency or facilitate discovery of new drug targets, a biotinylated congener of improgan (CC44) and several related compounds were synthesized and tested for antinociceptive activity. In rats and mice, intracerebroventricular (i.c.v.) administration of CC44 produced dose-dependent reductions in thermal nociceptive (tail flick and hot plate) responses, with 5-fold greater potency than improgan. CC44 also robustly attenuated mechanical (tail pinch) nociception in normal rats and mechanical allodynia in a spinal nerve ligation model of neuropathic pain. Similar to the effects of improgan, CC44 antinociception was reversed by the GABAA agonist muscimol (consistent with activation of analgesic circuits), and was resistant to the opioid antagonist naltrexone (implying a non-opioid mechanism). Also like improgan, CC44 produced thermal antinociception when microinjected into the rostral ventromedial medulla (RVM). Unlike improgan, CC44 (i.c.v.) produced antinociception which was resistant to antagonism by the cannabinoid CB1 antagonist/inverse agonist rimonabant. CC44 was inactive in mice following systemic administration, indicating that CC44 does not penetrate the brain. Preliminary findings with other CC44 congeners suggest that the heteroaromatic nucleus (imidazole), but not the biotin moiety, is required for CC44's antinociceptive activity. These findings demonstrate that CC44 is a potent analgesic compound with many improgan-like characteristics. Since powerful techniques are available to characterize and identify the binding partners for biotin-containing ligands, CC44 may be useful in searching for new receptors for analgesic drugs.
authors.affiliation: Center for Neuropharmacology and Neuroscience, Albany Medical College MC-136, 47 New Scotland Avenue, Albany, NY 12208, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Hoerbelt
authors.forename: Julia W
authors.initials: JW
authors.lastname: Nalwalk
authors.forename: James G
authors.initials: JG
authors.lastname: Phillips
authors.forename: Mark P
authors.initials: MP
authors.lastname: Wentland
authors.forename: Zhixing
authors.initials: Z
authors.lastname: Shan
authors.forename: Lindsay B
authors.initials: LB
authors.lastname: Hough
mesh_terms: D000700:Analgesics / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001360:Avidin / Q000378:metabolism; D019921:Biotinylation; D002927:Cimetidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006930:Hyperalgesia / Q000188:drug therapy; D008297:Male; D008526:Medulla Oblongata / Q000473:pathology; D051379:Mice; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D051381:Rats; D019809:Streptavidin / Q000378:metabolism
chemical_list: D000700:Analgesics; C099531:SKF 92374; D001360:Avidin; D002927:Cimetidine; D019809:Streptavidin
keywords: Analgesia; Biotin; Improgan; Neuropathic pain; Pain